Why Wegovy's Sales Potential Could Be Massively Understated

Why Wegovy's Sales Potential Could Be Massively Understated

Source: 
Motley Fool
snippet: 
  • Wegovy may generate more than $4 billion in revenue this year for Novo Nordisk.
  • A recent study showed the weight-loss drug can also help people bring down their risk of heart attack or stroke.
  • It's not unreasonable to expect that its peak sales could be in the tens of billions of dollars.